Psychedelic Mushrooms May Help Treatment Resistant Depression
The Carlat Addiction Treatment Report, Volume 4, Number 5, June 2016
https://www.thecarlatreport.com/newsletter-issue/catrv4n5/
Issue Links: Learning Objectives | Editorial Information
Topics: Depressive Disorder | Research Updates
Bret A. Moore, PsyD, ABPP
Psilocybin, a naturally occurring and psychedelic compound of the Psilocybe species of mushrooms, has garnered the most attention.
Psilocybin is essentially a serotonin 2A agonist. Theoretically, this action should mediate depressive symptoms, but we don’t know for sure because no available antidepressants are direct agonists of this receptor. Researchers from the United Kingdom set out to see if this is indeed the case.
You can't view details of this content, please login or buy subscription here
Bret A. Moore, PsyD, ABPP
Board-Certified Clinical Psychologist, San Antonio, TX
Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.